title: The future of rotavirus vaccines: a major setback leads to new opportunities.
authors.affiliation: Viral Gastroenteritis Section, Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. rglass@cdc.gov
authors.forename: Roger I
authors.initials: RI
authors.lastname: Glass
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Bresee
authors.forename: Umesh D
authors.initials: UD
authors.lastname: Parashar
authors.forename: Baoming
authors.initials: B
authors.lastname: Jiang
authors.forename: Jon
authors.initials: J
authors.lastname: Gentsch
mesh_terms: D000284:Administration, Oral; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003906:Developing Countries; D003968:Diarrhea, Infantile / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D017277:Drug Approval; D006801:Humans; D007223:Infant; D007443:Intussusception / Q000209:etiology*; D012307:Risk Factors; D012400:Rotavirus Infections / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000009:adverse effects*; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000009:adverse effects
chemical_list: D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated